£3.5m Local Growth Fund programme maps out future boost for engineering firm
Engineering firm Sylatech has received significant grant funding worth £450k from Let’s Grow North & East Yorkshire.
Kirkbymoorside-based Sylatech is hoping this capital investment will boost its growth. Let’s Grow is a £3.5m programme funded by York, North Yorkshire and East Riding LEP.
Sylatech’s grant is said to be the largest investment in this funding round for a single company.
Charlie Breese, Sylatech’s managing director, said: “We are two years into an ambitious five-year growth plan and are well on track to develop our core business by a minimum of £1m per annum, which secures further long-term job opportunities in Ryedale.”
Sylatech has recently achieved a profitable revenue growth of around 27 per cent, following an increase of 21 per cent last year.
Throughout 2018, Sylatech invested over £500k in capital and it plans to double such figure throughout this year.
Sylatech is currently in the advanced stages of agreeing a land acquisition adjacent to its current site in Kirkbymoorside, on which Sylatech plans to develop a sizeable 40,000 sq ft facility.
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular Yorkshire & The Humber morning email for free.
Have we made it harder for young people to succeed?
Celebrating Nissan's North East success story
Are you a meat proxy?
Engaging the five-generation workplace
Talent is an asset, not an operational resource
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't